Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (51-60 of 525) with videos related to

Pageof 53
Sort By:
Forensic Science International|August 26, 2006
Autopsy at 2 months after death: brain is satisfactorily preserved for neuropathologyEllen Gelpi, Matthias Preusser, Georg Bauer, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 21, 2007
Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidismMatthias Preusser, Melitta Kitzwoegerer, Herbert Budka, et al.
Therapeutic Advances in Medical Oncology|May 5, 2022
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycleAngelika M Starzer, Matthias Preusser, Anna S Berghoff
Cancers|September 28, 2021
Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?Hannah Christina Puhr, Matthias Preusser, Aysegül Ilhan-Mutlu
Chinese Journal of Cancer|December 12, 2013
Molecular biology of high-grade gliomas: what should the clinician know?Silvia Hofer, Elisabeth Rushing, Matthias Preusser, et al.
Current Opinion in Neurology|November 5, 2013
High-grade meningiomas: new avenues for drug treatment?Matthias Preusser, Anna S Berghoff, Andreas F Hottinger
The American Journal of Pathology|January 6, 2005
Subcellular localization of disease-associated prion protein in the human brainGábor G Kovács, Matthias Preusser, Michaela Strohschneider, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2014
Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinomaIldiko Mesteri, Sebastian F Schoppmann, Matthias Preusser, et al.
Clinical Neuropathology|October 27, 2015
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?Matthias Preusser, Anna S Berghoff, Wolfgang Wick, et al.
Clinical Neuropathology|June 23, 2012
Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkersAnna Sophie Berghoff, Harald Stefanits, Harald Heinzl, et al.
Pageof 53

Showing results (51-60 of 525) with videos related to

Sort By:
Pageof 53
Forensic Science International|August 26, 2006
Autopsy at 2 months after death: brain is satisfactorily preserved for neuropathologyEllen Gelpi, Matthias Preusser, Georg Bauer, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 21, 2007
Bilateral striopallidodentate calcification (Fahr's syndrome) and multiple system atrophy in a patient with longstanding hypoparathyroidismMatthias Preusser, Melitta Kitzwoegerer, Herbert Budka, et al.
Therapeutic Advances in Medical Oncology|May 5, 2022
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycleAngelika M Starzer, Matthias Preusser, Anna S Berghoff
Cancers|September 28, 2021
Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021?Hannah Christina Puhr, Matthias Preusser, Aysegül Ilhan-Mutlu
Chinese Journal of Cancer|December 12, 2013
Molecular biology of high-grade gliomas: what should the clinician know?Silvia Hofer, Elisabeth Rushing, Matthias Preusser, et al.
Current Opinion in Neurology|November 5, 2013
High-grade meningiomas: new avenues for drug treatment?Matthias Preusser, Anna S Berghoff, Andreas F Hottinger
The American Journal of Pathology|January 6, 2005
Subcellular localization of disease-associated prion protein in the human brainGábor G Kovács, Matthias Preusser, Michaela Strohschneider, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2014
Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinomaIldiko Mesteri, Sebastian F Schoppmann, Matthias Preusser, et al.
Clinical Neuropathology|October 27, 2015
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?Matthias Preusser, Anna S Berghoff, Wolfgang Wick, et al.
Clinical Neuropathology|June 23, 2012
Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkersAnna Sophie Berghoff, Harald Stefanits, Harald Heinzl, et al.
Pageof 53